Akebia Therapeutics, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to advancing innovative therapies for chronic kidney disease. With a robust pipeline that focuses on both the development and commercialization of kidney-related treatments, Akebia is committed to addressing the unmet medical needs of patients with renal conditions. The company's strategic initiatives leverage cutting-edge research and collaborations to enhance patient outcomes and expand its market presence in the evolving healthcare landscape.
Click "Analyze" to generate stock analysis
AKBA Price Trend and Signals
AKBA Option Volumes & Open Interests (aggregated)
AKBA Put Call Ratios and IV (aggregated)
AKBA Financials
2025-10-30Somewhat Bearishprice_signal
Half-yearly low detected.
2025-10-29Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.